Physician profile
Jonathan Liang
NPI 1942468947
$3,887.39
in general payments reported to CMS, 2019-2025
10 companies · $999 in 2025
The $999 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2021: $320 · 2022: $964 · 2023: $727 · 2024: $173 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,898.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $871.77 | 2019-2021 | |
| Medtronic, INC. | $778.55 | 2022-2025 | Propel, Fusion, Stealthstation S8 Platform |
| Stryker Corporation | $569.16 | 2022-2025 | Scopis Ent, Xpress Ent Dilation System, Clarifix Cryotherapy Device |
| Olympus America INC. | $535.79 | 2019-2023 | Rhino-Laryngo Videoscope |
| Genzyme Corporation | $380.00 | 2023-2025 | |
| Aerin Medical INC. | $256.61 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $241.20 | 2023-2025 | Dupixent |
| Inspire Medical Systems, INC. | $138.35 | 2025 | Inspire |
| Cochlear Americas | $76.02 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Neurent Medical Limited | $39.94 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.